ArticleJCI insight2023

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy.

Joseph H Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.